# Foghorn Therapeutics Inc.: Form 8-K, filed Jun 22, 2023

- Company: [Foghorn Therapeutics Inc.](/companies/fhtx.md) (CIK 1822462)
- Form: 8-K
- Filed: 2023-06-22
- Accepted by EDGAR: Jun 22, 2023, 20:13 ET
- Period: 2023-06-21
- Accession: 0001628280-23-023124
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1822462/000162828023023124/fhtx-20230621.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1822462/000162828023023124/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1822462/000162828023023124/fhtx-20230621.htm

Filed Jun 22, 2023.
Source: SEC EDGAR, the filing index for accession 0001628280-23-023124. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.